Demetrix scales up CBG production capabilities
Biotech company Demetrix has hit a big milestone in its efforts to commercialize the rare cannabinoid cannabigerol, or CBG. The Berkeley, Calif.-based company said that it had commenced 15,000-liter demo-scale production of CBG following several successful pilot-scale fermentations.
Read the full article HERE
